Differences in depressive thoughts between major depressive disorder, IFN-α-induced depression, and depressive disorders among cancer patients

Journal of Psychosomatic Research

Volumn 65, Issue 2, 2008, Pages 153-156

  Pasquini, Massimo ^a   Speca, Azzurra ^a   Mastroeni, Simona ^b   Delle Chiaie, Roberto ^a   Sternberg, Cora N ^c   Biondi, Massimo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Cancer; Core depressive thoughts; IFN induced depression; Major depressive disorder

Indexed keywords

ALPHA INTERFERON;

ARTICLE; BECK DEPRESSION INVENTORY; CANCER PATIENT; CONTROLLED STUDY; DEPRESSION; DISEASE CLASSIFICATION; EMOTION; GUILT; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION;

ADULT; CULTURE; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MOTIVATION; NEOPLASMS; PERSONALITY INVENTORY; PSYCHOMETRICS; THINKING;

EID: 48949116081     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2008.01.009     Document Type: Article

References (20)

1. Massie M. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 32 (2004) 57-71
2. Musselman D., Lawson D., Gumnick J., Manatunga A., Penna S., Goodkin R., Greiner K., Nemeroff C., and Miller A. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344 (2001) 961-966
3. Beratis S., Katrivanou A., Georgiou S., Monastirli A., Pasmatzi E., Gourzis P., and Tsambaos D. Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment. Psychosom Res 58 (2005) 15-18
4. Raison C., Borisov A., Broadwell S., Capuron L., Woolwine B., Jacobson I., Nemeroff C., and Miller A. Depression during pegylated interferon-alfa plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry 66 (2005) 41-48
5. Lotrich F., Rabinovitz M., Gironda P., and Pollock B. Depression following pegylated interferon-alpha: characteristics and vulnerability. J Psychosom Res 63 (2007) 131-135
6. Maes M., Bonaccorso S., Marino V., Puzella A., Pasquini M., Biondi M., Artini M., Almerighi C., and Meltzer H. Treatment with interferon-alpha (IFNa) of hepatitis-C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFNa-induced depressive and anxiety symptoms and immune activation. Mol Psychiatry 6 (2001) 475-480
7. Bonaccorso S., Marino V., Puzella A., Pasquini M., Biondi M., Artini M., Almerighi C., and Meltzer H Maes M. Increased depressive ratings in hepatitis-C patients receiving interferon-alpha (IFNa) based immunotherapy are related to IFNa-induced changes in the serotonergic system. J Clin Psychopharmacol 2 (2002) 475-480
8. Schiepers O., Wichers M., and Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 201-217
9. Dell'Osso L., Pini S., Maggi L., Rucci P., Del Debbio A., Carlini M., Baldini A., Ferrari G., Mancaa E., Beverini E., Amore M., Scarallo V., Semeraro Q., Brunetto M., Bonino F., and Maj M. Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders. J Psychosom Res 62 (2007) 349-355
10. Asnis G., and de La Garza R. Interferon-induced depression: strategies in treatment. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 808-818
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
12. Beck A., and Ward C. Reliability of psychiatric diagnoses: s study of clinical judgments and ratings. Am J Psychiatry 19 (1962) 351-356
13. Stata Corporation (2005), Stata Press, College Station, TX
14. Capuron L., Gumnick J., Musselman D., Lawson D., Reemsnyder A., Nemeroff C., and Miller A. Neurobehavioral effects of interferon-a in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26 (2002) 643-652
15. Corcos M., Guilbaud O., Hjalmarsson L., Chambry J., and Jeammet P. Cytokines and depression: an analogic approach. Biomed Pharmacother 56 (2000) 105-110
16. de Beaurepaire R. Questions raised by the cytokine hypothesis of depression. Brain Behav Immun 16 (2002) 610-617
17. Raison C., and Miller A. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 54 (2003) 283-294
18. Dantzer R., O'Connor J., Freund G., Johnson R., and Kelley K. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9 (2008) 46-57
19. Dieperink E., Ho S., Thuras P., and Willenbring M. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 44 (2003) 104-112
20. Demyttenaere K., and De Fruyt J. Getting what you ask for: on the selectivity of depression rating scales. Psychother Psychosom 72 (2003) 61-70